Clinical development of RET inhibitors in RET-rearranged non-small cell lung cancer: update
Precision oncology is now the evidence-based standard of care for the management of many advanced non-small cell lung cancers (NSCLC). Notably, new molecular profiling technologies have permitted dynamic growth in the identification of actionable driver oncogenes including RET rearrangements. RET on...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Frontiers Media S.A.,
2018-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|